Hong Kong Electrical Stock News

Beijing Chunlizhengda Medical Instruments Co., Ltd.'s ( HKG:1858 ) earnings announcement last week was disappointing...

Soft earnings didn't appear to concern Hygeia Healthcare Holdings Co., Limited's ( HKG:6078 ) shareholders over the...

Despite announcing strong earnings, Wanguo Gold Group Limited's ( HKG:3939 ) stock was sluggish. We think that the...

Canggang Railway Limited's ( HKG:2169 ) robust recent earnings didn't do much to move the stock. We believe that...

Investors were disappointed with Shanghai Conant Optical Co., Ltd.'s ( HKG:2276 ) earnings, despite the strong profit...

The subdued stock price reaction suggests that YuanShengTai Dairy Farm Limited's ( HKG:1431 ) strong earnings didn't...

Consun Pharmaceutical Group Limited's ( HKG:1681 ) healthy profit numbers didn't contain any surprises for investors...

The subdued market reaction suggests that Giant Biogene Holding Co., Ltd.'s ( HKG:2367 ) recent earnings didn't contain...

China Resources Mixc Lifestyle Services Limited's ( HKG:1209 ) robust earnings report didn't manage to move the market...

Shanghai Fudan Microelectronics Group Company Limited's ( HKG:1385 ) recent weak earnings report didn't cause a big...

Even though Sino Biopharmaceutical Limited's ( HKG:1177 ) recent earnings release was robust, the market didn't seem to...

Despite posting some strong earnings, the market for Melco International Development Limited's ( HKG:200 ) stock hasn't...

Wuling Motors Holdings Limited ( HKG:305 ) just reported healthy earnings but the stock price didn't move much...

A lackluster earnings announcement from COSCO SHIPPING Development Co., Ltd. ( HKG:2866 ) last week didn't sink the...

Despite posting some strong earnings, the market for Continental Aerospace Technologies Holding Limited's ( HKG:232...

Investors signalled that they were pleased with Datang International Power Generation Co., Ltd.'s ( HKG:991 ) most...

Lee & Man Paper Manufacturing Limited ( HKG:2314 ), might not be a large cap stock, but it saw significant share price...

Shareholders appeared unconcerned with China Travel International Investment Hong Kong Limited's ( HKG:308 ) lackluster...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see The...

As global markets navigate the uncertainty of central bank policies and geopolitical tensions, Asian equities have shown resilience with mixed performances across major indices. In this environment, identifying stocks that are estimated to be trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential market inefficiencies. A good stock in such conditions is often characterized by strong fundamentals and a robust business model that can...

Amidst a backdrop of geopolitical tensions and central banks holding interest rates steady, Asian markets are navigating a complex landscape shaped by energy price fluctuations and evolving economic policies. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

NetEase stock in focus after recent share performance NetEase (SEHK:9999) has come back into focus for investors after recent share performance, with the stock returning 3.7% over the past week and roughly 3.8% over the past month. This short term move sits alongside a year to date return of a 20.7% decline and a past 3 months return of a 5.8% decline, prompting closer attention to how the company’s fundamentals line up with current pricing. See our latest analysis for NetEase. Recent trading...

Clinical trial approval and what it means for investors United Laboratories International Holdings (SEHK:3933) has drawn fresh attention after regulators in China approved the clinical trial application for its dupilumab biosimilar targeting atopic dermatitis, a step that highlights progress in its autoimmune pipeline. See our latest analysis for United Laboratories International Holdings. The share price has recently picked up, with a 1-day share price return of 2.77% taking the stock to...

Sinotrans Limited has released its first-quarter 2026 results, reporting CNY 21,549.36 million in revenue, down from CNY 23,771.71 million a year earlier, while net income edged up to CNY 681.45 million and basic earnings per share from continuing operations rose to CNY 0.095. This combination of lower revenue but slightly higher profitability suggests Sinotrans managed to improve cost efficiency or business mix despite a softer top line. We will now examine how Sinotrans’s higher net income...